PARP抑制剂治疗BRCA2基因突变晚期胰腺癌1例
Journal of Hebei North University(Natural Science Edition)（2022）
Abstract
胰腺癌是一种较常见的消化道恶性肿瘤,晚期胰腺癌药物治疗效果欠佳,预后极差.报道1例BRCA2基因突变晚期胰腺癌使用PARP抑制剂单药及联合免疫检查点抑制剂取得较好疗效,并结合文献进行讨论.
MoreAI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined